Access the cutting-edge science driving the next wave of developments and potential applications for medical cannabis. Renowned researchers and practitioners will present their latest findings.
CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders for the ultimate opportunity to make an impact in the field. We haven't had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel's most cosmopolitan and vibrant city - Tel Aviv.
Prof., Institute for Drug Research, The Hebrew University of Jerusalem, Israel
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel
Ph.D, Head of Scientific Advisory Committee; Head, Laboratory of Cancer Biology and Cannabinoid Research, Faculty of Biology and Technion Integrated Cancer Center, Technion- Israel Institute of Technology, Haifa, Israel
Prof., MD, Neurological Rehabilitation, Cannabis Physician, Chair, UK Medical Cannabis Clinicians Society, Chair, UK Cannabis Industry Council, Director, Maple Tree Medical Cannabis Consultancy, UK
Ph.D, Senior Research Scientist, Head of the 'Laboratory of Cannabis Physiology and Agronomy', Agricultural Research Organization, Volcani Center, Israel
M.D., Founding member, Society of Cannabis Clinicians, USA
PhD, MS, Professor and Chair of Biochemistry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy
Ph.D, Senior Research Associate, Regional Alcohol and Drug Abuse Center, Ben Gurion University of the Negev, Israel
Chief Operating Officer, Cann 10 - Medical Cannabis, Israel
Follow the latest updates and join the discussion online.